Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001415889-25-000622

Chief Business Officer gave up 40,664 shares (to pay taxes)

  • Chief Business Officer acquired 91,900 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Loerop James Chief Business Officer 2024-12-31 Option exercise +73,750 107,767 D: show line 1 in the form
Loerop James Chief Business Officer 2024-12-31 Shares withheld for taxes −32,089 $2.48 $79,581 75,678 D: show line 2 in the form
Loerop James Chief Business Officer 2025-01-02 Option exercise +18,150 93,828 D: show line 3 in the form
Loerop James Chief Business Officer 2025-01-02 Shares withheld for taxes −8,575 $2.48 $21,266 85,253 D: show line 4 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Loerop James Chief Business Officer 2024-12-31 Option exercise · Restricted Stock Units −73,750 73,750 D: show line 5 in the form
Loerop James Chief Business Officer 2025-01-02 Grant or award · Restricted Stock Units +55,000 55,000 D: show line 6 in the form
Loerop James Chief Business Officer 2025-01-02 Option exercise · Restricted Stock Units −18,150 36,850 D: show line 7 in the form
Loading xslF345X05/form4-01032025_060104.xml…